| UM | uveal melanoma |
| BT | brachytherapy |
| PT | proton therapy |
| SRT | stereotactic radiotherapy |
| SRS | stereotactic radiosurgery |
| TTT | transpupillary thermotherapy |
| PDT | photodynamic therapy |
| Ru-106 | ruthenium-106 |
| I-125 | iodine-125 |
| COMS | Collaborative Ocular Melanoma Study |
| IOL | intraocular lens |
| BCVA | best corrected visual acuity |
| USG | ultrasonography |
| UBM | ultrasound biomicroscopy |
| AJCC | American Joint Committee on Cancer |
| OCT | optical coherence tomography |
| CGE | Cobalt Gray Equivalent |
| Anti-VEGF | anti-vascular endothelial growth factor |
| TCA | triamcinolone acetonide |
| SD | standard deviation |
| Ru-106 CCB brachytherapy | ruthenium-106 brachytherapy with CCB plaque |
| Ru-106 COB brachytherapy | ruthenium-106 brachytherapy with COB plaque |
| Ru-106 CCB (in tables) | ruthenium-106 brachytherapy with CCB plaque |
| Ru-106 COB (in tables) | ruthenium-106 brachytherapy with COB plaque |
| I-125 (in tables) | iodine-125 brachytherapy |
| mm | millimeter |
| Gy | gray |
| HR | hazard ratio |
| CI | confidence interval |
| TBUT | tear break-up time |